Gilead Sciences obtains FDA OK for new indication of Trodelvy
Gilead Sciences' Trodelvy now can be used as a treatment in adult patients with unresectable locally advanced or metastatic TNBC who have received two or more prior systemic therapies, at least one of them for metastatic disease.